People channel feed

An­oth­er round of con­sol­i­da­tion is com­ing, FDA com­mis­sion­er tells staff

Yesterday
FDA+

Ver­tex lays off 125 work­ers af­ter type 1 di­a­betes cell ther­a­py failed study in March

4 days ago
Pharma
Cell/Gene Tx

For­mer a16z biotech in­vest­ment leader Vi­jay Pande ex­its the VC firm

5 days ago

Re­cur­sion to lay off 20% of staff, a month af­ter slash­ing its pipeline

5 days ago
AI

Biotech slump forces Re­silience to wind down six man­u­fac­tur­ing sites, us­ing bank­rupt­cy move

5 days ago
Manufacturing

Bio­phar­ma lead­ers carv­ing a path for the in­dus­try’s LGBTQ+ com­mu­ni­ty

Last week
Special

Ex-HHS work­ers ac­cuse Trump ad­min­is­tra­tion of us­ing flawed da­ta to is­sue fir­ings

Last week
Pharma
Law

Strug­gling biotechs suc­cumb to icy mar­ket, as mon­ey dries up and clin­i­cal bets don’t pay off

Last week
Pharma
In Focus

Q&A: San­doz CEO Richard Saynor on gener­ic GLP-1s, Trump's in­dus­try im­pact, and Mark Cuban's com­pa­ny

Last week
Pharma
Manufacturing

DOGE set to­day as their last day at FDA. In­stead, they're con­tin­u­ing to get full pay and don't work

Last week
FDA+

Q&A: Why for­mer Sen. Kyrsten Sine­ma is back­ing a psy­che­del­ic med­i­cine with po­ten­tial­ly more up­side, but more risk

3 weeks ago
R&D

In­sur­ance start­up De­vot­ed Health cuts 5% of work­ers in small lay­off

3 weeks ago
Startups
Health Tech

Weeks af­ter TIG­IT fail, iTeos de­cides to wind down

3 weeks ago
Startups

Ser­no­va chair re­signs fol­low­ing in­sid­er trad­ing in­dict­ment over No­var­tis-Chi­nook deal

3 weeks ago
Law

Bound­less Bio changes plans for can­cer drug af­ter tox­i­c­i­ty is­sues

3 weeks ago
R&D

Prothena’s amy­loi­do­sis drug flops again, spend­ing and staff cuts are on the way

3 weeks ago
R&D

About 5% of CBER and CDER left af­ter FDA staff cuts, analy­sis finds

4 weeks ago
FDA+

Up­dat­ed: Eikon Ther­a­peu­tics cuts staff for the sec­ond time in less than two years

4 weeks ago

Ex­clu­sive: Weight loss start­up Cal­i­brate swaps CEOs in lat­est lead­er­ship shake­up

4 weeks ago
Startups
Health Tech

Prime Med­i­cine side­lines on­ly clin­i­cal pro­gram, re­places CEO and lays off some staff

4 weeks ago
R&D
Cell/Gene Tx

Up­dat­ed: No­vo Nordisk CEO to step down amid stock de­cline, time­line for suc­ces­sor un­known

5 weeks ago
Pharma

Bris­tol My­ers CEO says Amer­i­ca’s bio­phar­ma pole po­si­tion is not guar­an­teed

5 weeks ago
Pharma

Unit­ed­Health Group CEO An­drew Wit­ty steps down

Last month
Health Tech

Up­dat­ed: To spin off or not to spin off? Gala­pa­gos backpedals on sep­a­ra­tion plans, CEO Paul Stof­fels ex­its ear­ly

Last month
Cell/Gene Tx
1234 Next page Last page
A service from the Financial Times